Aurobindo Pharma

Aurobindo Pharma Limited
Company type	Public
Traded as	NSE: AUROPHARMA ; BSE: 524804
Industry	Pharmaceuticals
Founded	1986
Founders	V. Ramprasad Reddy; K. Nityananda Reddy
Headquarters	Hyderabad, Telangana, India
Products	Pharmaceuticals; generic drugs; over-the-counter drugs; vaccines; diagnostics; contact lenses; animal health;
Revenue	₹23,290 crore (US$2.9 billion) (2020)
Operating income	₹4,063 crore (US$510 million) (2020)
Net income	₹2,844 crore (US$360 million) (2020)
Total assets	₹28,926 crore (US$3.6 billion) (2020)
Total equity	₹16,751 crore (US$2.1 billion) (2020)
Number of employees	23,000 (2020)
Website	www.aurobindo.com

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.